Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Portal   Teaching
X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA



How to contribute / Instructions to Authors

Collaborations are most welcome!
The Atlas is indexed by the Current Web Contents, and hyperlinked by SwissProt, the Mitelman Database , GeneCards, and many others.

  • I- Cards
  • II- Deep Insights
  • III- Case reports
  • IV- Iconography
  • V- Updates
  • VI- Conflicts of Interest
  • VII- Privacy and Confidentiality - Iconography
  • VIII- Editorial policies
  • IX- Creative Commons
  • X- HONcode
  • Editorial Correspondance
  • I- CARDS
    You are welcome to write on: genes, cytogenetic entities, leukaemias, solid tumours, and cancer prone diseases.
    It is ESSENTIAL to use the guidelines herein given:


    Lists (non-exhaustive) of entities "FOR SALE" where contributions are particularly welcome
  • List of GENES
  • List of LEUKAEMIAS
  • List of SOLID TUMOURS
  • List of CANCER PRONE DISEASES


  • Criteria of relevance for an entity:
    - Genes: hybrid gene found in at least 1 cancer case, or gene amplification or homozygous deletion found in a significant subset of cases in a given cancer-type.
    - Chromosome structural aberrations: found in at least 2 cases in a given cancer, or in only 1 case if the hybrid gene is also described.
    - Cancer-prone disease: significant aggregation of a cancer-type found within families, or a patient with a germ-line mutation (first allele) and a somatic mutation in the tumour (second allele) of a gene known to be implicated in this tumour-type.
    Please, contact us before undertaking any work, to avoid double (conflicting) reports.

    II- DEEP INSIGHTS
    These papers do not follow the above mentioned patterns; they are written as traditional papers at the author's convenience. They must be composed of an abstract and paragraphs with headings.

    III- CASE REPORTS
    This section is dedicated to recurrent -but rare- chromosomes abnormalities in leukaemias / lymphomas. As stated, cases of interest shall be :
    1. recurrent (i.e. previously described in at least 1 case),
    2. rare (previously described in less than 20 cases),
    3. with well documented clinics and laboratory findings,
    4. with iconography on chromosomes,
    5. in cases of hematological malignancy.
    Please, use: Submission form for CASE REPORTS

    IV- ICONOGRAPHY
    Iconographies are most welcome (accompanied with a legend, and the names and first name of the colleagues to be acknowledged: " Courtesy .... " ).
    - In particular chromosome structural anomalies (G- and R- bandings and others), even if the anomaly is already in the Atlas in 1 or 2 samples, and FISH images;
    - But also drawings of genes and proteins, pathology images, X-Rays.
    - Maximal width for drawings is 17 cm; for pathology images, it is preferable that the length does not encompass half of the width.
    - Please use preferably Arial 9 point for lettering.
    - Images should be sent by e-mail, preferably in PPT for drawings, and in PNG, JPG, GIF, or PSD for photographs: chromosomes, histo-pathology, radiographs, ... PPT, PNG, PSD, JPG, GIF are workable; the desk may have problems with other formats.
    - The Editor keeps the right to process drawings for them to conform to our editorial policies.

    Please, refer to Copyright Notice.

    V- Updates
    The rule for updates in the Atlas is to start from the current paper and modify it, add on it, as a sort of collaboration over times between two authors. We want to acknowledge the work of past, as well as present and future authors of the Atlas, because the Atlas is indebted to all the colleagues participating in it.
    So, please, for an update: go to the existing card / select all / copy and paste in a Word file / put in green what should be deleted / add in red / comment in blue / and send it back to us by e-mail.

    VI- Conflicts of Interest
    Authors must state explicitly whether potential conflicts do or do not exist. Reviewers must disclose to editors any conflicts of interest that could bias their opinions of the manuscript. The editor and the editorial board members must disclose any potential conflict.

    VII- Privacy and Confidentiality - Iconography
    Patients have a right to privacy. Identifying details should be omitted. If complete anonymity is difficult to achieve, informed consent should be obtained.

    VIII- Editorial policies
    You will find additional publications policies and requirements applied in the Atlas at the site of the International Committee of Medical Journal Editors: Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication - Updated October 2004

    IX- Creative Commons
    Creative Commons License   This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License.

    X- HONcode
    This website is certified by Health On the Net Foundation. Click to verify.    This site complies with the HONcode standard for trustworthy health information.



    Editorial Correspondence to:
    Jean-Loup HURET, Genetics, Dept Medical Information,
    University Hospital, F-86021 Poitiers, FRANCE.
    tel +33 5 49 44 45 46 or +33 5 49 45 47 67
    jlhuret@AtlasGeneticsOncology.org and jlhuret@univ-poitiers.fr



    Rules, Copyright Notice and Disclaimer

    Advertising policy
    The site does not display advertisements, and does not host or receive funding from advertising or from the display of commercial content.
    Corporate patronage is welcome.

    Property
    As cards are to evolve with further improvements and updates from various contributors, the property of the cards belongs to the editor, and modifications will be made without authorization from the previous contributor (who may, nonetheless, be asked for refereeing); contributors are listed in an edit history manner. Nonetheless, contributors keep the rights to use further the content of their papers published in the Atlas, provided that the source is cited.

    Copyright
    The information in the Atlas of Genetics and Cytogenetics in Oncology and Haematology is issued for general distribution. All rights are reserved. The information presented is protected under international conventions and under national laws on copyright and neighboring rights. Commercial use is totally forbidden. Information extracted from the Atlas may be reviewed, reproduced or translated for research or private study but not for sale or for use in conjunction with commercial purposes. Any use of information from this web site should be accompanied by an acknowledgment of the Atlas as the source, citing the uniform resource locator (URL) of the article. Reference to any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement, recommendation, or favoring. The views and opinions of contributors and authors expressed herein do not necessarily state or reflect those of the Atlas editorial staff or of the web site holder, and shall not be used for advertising or product endorsement purposes. The Atlas does not makes any warranty, express or implied, including the warranties of merchantability and fitness for a particular purpose, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, and shall not be liable whatsoever for any damages incurred as a result of its use. In particular, information presented in the Atlas is only for research purpose, and shall not be used for diagnosis or treatment purposes. No responsibility is assumed for any injury and/or damage to persons or property for any use or operation of any methods products, instructions or ideas contained in the material herein.


    X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

    Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Portal   Teaching

    Last update : Fri May 11 15:09:02 CEST 2012